News

Novant Health announced that it will soon be the first healthcare provider in the Carolinas to offer an incision-free brain “surgery” technique to treat essential tremor and tremors caused by Parkinson’s disease. The technique, called MR-guided focused ultrasound, uses magnetic resonance imaging (MRI) to identify brain…

Scientists have found that switching off TET2, a gene that provides instructions to make an enzyme that alters the activity of certain genes, can lower inflammation and neurodegeneration associated with Parkinson’s disease. Authors of a study with those findings suggest that reducing the activity of this master gene…

The Michael J. Fox Foundation (MJFF) is supporting six different funding programs for projects related to Parkinson’s disease, with applications now being accepted. The six  Requests for Applications (RFAs) are meant to support work focused on different aspects of Parkinson’s research, from data analysis…

The Patient-Centered Outcomes Research Institute (PCORI) has awarded the Parkinson’s Foundation and the University of Rochester Medical Center $1.4 million to establish palliative care as a standard across the foundation’s Center of Excellence Network in the U.S. This initiative,  “Implementing Team-based Outpatient Palliative Care in Parkinson Foundation Centers of Excellence,”…

Estimating the severity of Parkinson’s disease may be possible by remotely measuring and analyzing physical activity as patients’ motor impairment increases, research led by scientists at IBM Research suggests. The method uses an artificial intelligence (AI) algorithm that examines movement data sent from wrist-worn accelerometers. It can be…

The small molecule anle138b has shown “excellent” safety and tolerability profiles in a first study in healthy volunteers, and reached therapeutic dose levels in the blood, according to its developer Modag. These results enabled Modag to secure an additional $1.4 million in funding from the Michael J.

The content of dreams, namely dreams with negative emotions, seems to significantly predict long-term cognitive decline in people with Parkinson’s disease, a recent longitudinal study suggests. The association was independent of factors known to impact dream content and cognitive impairment in these patients, its researchers noted. The…